MENU
ALT
AS OF
Feb 3 closing price
Price
$5.47
Change
+$1.47 (+36.75%)
Capitalization
685.02M
50 days until earnings call
Intraday BUY SELL Signals
+Compare
ALT
Stock ticker: NASDAQ
AS OF
Feb 3 closing price
Price
$5.47
Change
+$1.47 (+36.75%)
Capitalization
685.02M

ALT Altimmune Forecast, Technical & Fundamental Analysis

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases... Show more

ALT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ALT with price predictions
Feb 03, 2026

ALT in upward trend: price rose above 50-day moving average on January 21, 2026

ALT moved above its 50-day moving average on January 21, 2026 date and that indicates a change from a downward trend to an upward trend. In of 34 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 06, 2026. You may want to consider a long position or call options on ALT as a result. In of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ALT just turned positive on January 12, 2026. Looking at past instances where ALT's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for ALT crossed bullishly above the 50-day moving average on January 26, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

The 50-day moving average for ALT moved above the 200-day moving average on January 22, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where ALT advanced for three days, in of 280 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 168 cases where ALT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for ALT moved out of overbought territory on January 28, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 52 cases where ALT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ALT broke above its upper Bollinger Band on January 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ALT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.691) is normal, around the industry mean (27.519). P/E Ratio (0.000) is within average values for comparable stocks, (51.491). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.893). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. ALT's P/S Ratio (10000.000) is very high in comparison to the industry average of (331.843).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ALT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ALT is expected to report earnings to rise 18.62% to -24 cents per share on March 26

Altimmune ALT Stock Earnings Reports
Q4'25
Est.
$-0.25
Q3'25
Beat
by $0.06
Q2'25
Beat
by $0.04
Q1'25
Beat
by $0.12
Q4'24
Beat
by $0.01
The last earnings report on November 06 showed earnings per share of -20 cents, beating the estimate of -27 cents. With 4.57M shares outstanding, the current market capitalization sits at 685.02M.
A.I. Advisor
published General Information

General Information

a developer of biopharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Miscellaneous Commercial Services
Address
910 Clopper Road
Phone
+1 240 654-1450
Employees
59
Web
https://www.altimmune.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
YFSIX17.700.30
+1.72%
AMG Yacktman Global I
IARFX16.040.04
+0.25%
Invesco Real Estate R6
DIFIX12.690.03
+0.24%
MFS Diversified Income I
NUGCX34.54-0.15
-0.43%
Nuveen Global Dividend Growth C
VSTIX68.76-0.59
-0.85%
VALIC Company I Stock Index

ALT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ALT has been loosely correlated with INDP. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ALT jumps, then INDP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALT
1D Price
Change %
ALT100%
-0.89%
INDP - ALT
45%
Loosely correlated
-8.64%
ACHV - ALT
44%
Loosely correlated
+2.87%
KROS - ALT
39%
Loosely correlated
+2.74%
AMRN - ALT
38%
Loosely correlated
+0.50%
RXRX - ALT
35%
Loosely correlated
-0.24%
More

Groups containing ALT

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALT
1D Price
Change %
ALT100%
-0.89%
commercial service
theme (76 stocks)
29%
Poorly correlated
-4.08%
biopharmaceuticals
theme (46 stocks)
26%
Poorly correlated
-0.19%